• Latest Posts

Seven pharma companies form alliance to prepare for future pandemics 

Boost for Charcot-Marie-Tooth patients as Novartis acquires DTx Pharma

Novartis acquires Chinook Therapeutics for $3.2B

Chronic myeloid leukemia: Novartis survey signals need for better patient-physician communication 

Novartis buys AVROBIO cystinosis gene therapy program for $87.5M

Pharming immunodeficiency drug given FDA approval

In Depth 17 Jan 2023

Cell and gene therapies gain momentum in Basel

STALICLA signs agreement with Novartis on neurodevelopmental disorders

Novartis Biome UK Heart Health Catalyst 2022 winners announced

Allarity Therapeutics drug no longer commercially viable or in shareholders’ best interest

In Depth 14 Jul 2022

Radiopharmaceuticals gain traction for cancer theranostics potential

Novartis Pharmaceuticals UK launches health-tech investor partnership for cardiovascular care